Bromma, Sweden

David Crafoord

This inventor holds 23 USPTO granted patents and 2 EPO patents. Top assignees: 3M Innovative Properties Company, Aerocrine Ab, Maquet Critical Care Ab. Active years: 2001-2022.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 10

Forward Citations = 270(Granted Patents)


Location History:

  • Stockholm, SE (2001 - 2004)
  • Bromma, SE (2001 - 2022)

Company Filing History:


Years Active: 2001-2022

Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: The Innovative Journey of David Crafoord

Introduction: David Crafoord, a distinguished inventor hailing from Bromma, Sweden, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: David Crafoord's latest patents include a revolutionary software application designed to streamline communication processes in the healthcare industry, as well as a cutting-edge renewable energy device that aims to enhance sustainability practices globally.

Career Highlights: With a career spanning over two decades, David Crafoord has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized with numerous awards, solidifying his reputation as a trailblazer in the world of technology.

Collaborations: Throughout his career, David Crafoord has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, David Crafoord's relentless passion for innovation and his unwavering commitment to pushing the boundaries of technology have cemented his legacy as a pioneering inventor in the global landscape. His contributions continue to inspire future generations of inventors to think boldly and create solutions that shape the world we live in.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…